Illumina, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ILU.F | NTRA | QGEN | 4544.T | NEO | A | |
|---|---|---|---|---|---|---|
| Market cap | 37.55B | 57.16B | 10.39B | 201.92B | 2.09B | 48.72B |
| P/E (TTM) | 54.2 | — | 25.5 | 21.9 | — | 34.1 |
| Forward P/E | 49.6 | -2,230.0 | 19.3 | 36.6 | 47.5 | 25.6 |
| Price/book | 14.9 | 31.3 | 3.1 | 1.5 | 2.6 | 6.6 |
| Dividend yield | — | — | 0.70% | 3.36% | — | 0.57% |
| 1-year change | +177.97% | +111.99% | +1.32% | −6.21% | +63.06% | +20.54% |
| Today | +4.81% | −4.07% | +0.65% | +0.48% | −4.52% | −2.79% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All ILU.F news ›Illumina: NovaSeq X And Consumables Sustain Momentum
Illumina (ILMN) is rated a Buy, driven by robust demand for consumables and NovaSeq X instruments, supported by favorable market dynamics and regulatory... - Illumina (ILMN) is rated a Buy, driven by robust demand for consumables and…
Illumina Adds AI-Driven Workflow and Variant Prioritization Tools to BioInsight Platform
Oct 21, 2026 | Analytical Software Systems | Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics processes and accelerate research from sequencing data to discovery.…
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery
Future-ready: Built to accelerate performance and value All Kits & Reagents Detect five DNA bases in a single assay while delivering concurrent genetic and epigenetic insights All Selection & Planning Tools Take the guesswork out of your…
Illumina (NASDAQ:ILMN) Price Target Raised to $300.00
Posted by Danessa Lincoln on Oct 22nd, 2026 Illumina (NASDAQ:ILMN – Free Report) had its price target raised by Canaccord Genuity Group from $205.00 to $300.00 in a research note released on Monday, Marketbeat Ratings reports. They…
Illumina (ILMN) Receives a Buy from J.P. Morgan
J.P. Morgan analyst Casey Woodring maintained a Buy rating on Illumina yesterday and set a price target of $320.00. The company’s shares closed yesterday at $262.54. Woodring covers the Healthcare sector, focusing on stocks such as…
Illumina, Inc. Introduces Three Early-Access Capabilities On Its BioInsight Platform
Illumina, Inc. introduced three early-access capabilities on its BioInsight Platform that help researchers move faster from sequencing data to discovery. BioInsight Platform Workflow Orchestrator ...
Why Illumina (ILMN) Stock Is Down Today
Shares of genomics company Illumina (NASDAQ: ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation gene sequencing machine, taking aim at the company's market dominance. Roche's new "Axelios"…
Illumina launches AI-powered tools for faster, scalable genomic research and discovery
Illumina introduced three early-access AI-driven capabilities on its BioInsight Platform—DRAGEN Ultra, Workflow Orchestrator, and Learning Cohorts—to accelerate genomic research. These tools automate sequencing workflows, prioritize…
Illumina Establishes New Dealer Agreement to Support Financing
Illumina ( (ILMN) ) has shared an announcement. On October 13, 2026, Illumina, Inc. entered into a material definitive agreement formalized through a dealer agreement with an unnamed dealer party. The filing, signed by Chief Financial…
Illumina To Webcast Upcoming Investor Conference
TradingView SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced that members of its management team will participate at the following investor conference: The fireside chat is scheduled for 07:15am PT (10:15am…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com18
-
tradingview.com8
-
theglobeandmail.com7
-
stocktitan.net5
-
newsfilecorp.com4
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 67 articles, not a forecast.